Your browser doesn't support javascript.
loading
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Butt, Jawad H; Kondo, Toru; Yang, Mingming; Jhund, Pardeep S; Docherty, Kieran F; Vaduganathan, Muthiah; Claggett, Brian L; Hernandez, Adrian F; Lam, Carolyn S P; Inzucchi, Silvio E; Martinez, Felipe A; de Boer, Rudolf A; Kosiborod, Mikhail N; Desai, Akshay S; Køber, Lars; Ponikowski, Piotr; Sabatine, Marc S; Shah, Sanjiv J; Zaozerska, Natalia; Wilderäng, Ulrica; Bengtsson, Olof; Solomon, Scott D; McMurray, John J V.
Afiliação
  • Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Kondo T; Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Yang M; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Jhund PS; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Vaduganathan M; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Claggett BL; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Hernandez AF; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lam CSP; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Inzucchi SE; Duke University Medical Center, Durham, NC, USA.
  • Martinez FA; National Heart Centre Singapore, Singapore.
  • de Boer RA; Duke-National University of Singapore, Singapore.
  • Kosiborod MN; Yale School of Medicine, New Haven, CT, USA.
  • Desai AS; University of Cordoba, Cordoba, Argentina.
  • Køber L; Erasmus Medical Center, Rotterdam, The Netherlands.
  • Ponikowski P; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
  • Sabatine MS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Shah SJ; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Zaozerska N; Department of Heart Disease, Wroclaw Medical University, Wroclaw, Poland.
  • Wilderäng U; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Bengtsson O; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Solomon SD; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • McMurray JJV; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Eur Heart J ; 44(24): 2170-2183, 2023 06 25.
Article em En | MEDLINE | ID: mdl-37220172

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Doença Arterial Periférica / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Doença Arterial Periférica / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido